HealthDay (1/18, Preidt) reported that, according to a study published in the Jan. issue of the Archives of Dermatology, "the cost of treating psoriasis is rising faster than inflation." Investigators found that "trends in the average wholesale price of brand-name psoriasis therapies from 2000 through 2008 demonstrate an average increase of 66 percent." Notably, "costs of several brand-name psoriasis drugs greatly outpaced the rate of inflation for all items and all prescription drugs," they wrote.